| Title |
Federal judge invalidates icosapent ethyl patents — but on the basis of a common statistical mistake
|
|---|---|
| Published in |
Nature Biotechnology, August 2020
|
| DOI | 10.1038/s41587-020-0616-y |
| Pubmed ID | |
| Authors |
Gregory Curfman, Deepak L. Bhatt, Michael Pencina |
X Demographics
The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 10 | 34% |
| Spain | 1 | 3% |
| Chile | 1 | 3% |
| United Kingdom | 1 | 3% |
| Brazil | 1 | 3% |
| India | 1 | 3% |
| Singapore | 1 | 3% |
| Unknown | 13 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 25 | 86% |
| Practitioners (doctors, other healthcare professionals) | 3 | 10% |
| Scientists | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 8 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 3 | 38% |
| Other | 2 | 25% |
| Professor | 1 | 13% |
| Unknown | 2 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 2 | 25% |
| Neuroscience | 1 | 13% |
| Business, Management and Accounting | 1 | 13% |
| Unknown | 4 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2023.
All research outputs
#1,422,389
of 25,663,438 outputs
Outputs from Nature Biotechnology
#2,335
of 8,603 outputs
Outputs of similar age
#39,442
of 427,411 outputs
Outputs of similar age from Nature Biotechnology
#64
of 98 outputs
Altmetric has tracked 25,663,438 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,603 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.2. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,411 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.